We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics
ALDX

28 hedge funds and large institutions have $18.3M invested in Aldeyra Therapeutics in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 21 → 28 (+7)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

0.56% less ownership

Funds ownership: 45.59% → 45.02% (-0.56%)

21% less capital inflows, than outflows

Capital inflows: $1.01M | Capital outflows: $1.27M

Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DCM
DAFNA Capital Management
California
+$847K
2
CL
Croft-Leominster
Maryland
+$81.7K
3
FMA
FNY Managed Accounts
New York
+$31.2K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$14.7K
5
UBS Group
UBS Group
Switzerland
+$13K

Top Sellers

Rank Fund Capital Flow
1
Deerfield Management
Deerfield Management
New York
-$1.05M
2
SM
Sabby Management
Florida
-$133K
3
Millennium Management
Millennium Management
New York
-$48K
4
Weiss Multi-Strategy Advisers
Weiss Multi-Strategy Advisers
New York
-$23.2K
5
Morgan Stanley
Morgan Stanley
New York
-$17.5K

ALDX Hedge Fund Activity: Q1 2016 in Review

28 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q1 2016, worth a combined $18.3M — down 39% from $30M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new ALDX positions and 0 closed out — a net gain of 7 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $847K. The largest seller was Deerfield Management, cutting an estimated $1.05M.

  • 28 institutional investors held Aldeyra Therapeutics (ALDX) as of Q1 2016, up from 21 in Q4 2015.
  • Funds reported $18.3M of Aldeyra Therapeutics stock for Q1 2016, down 39% quarter-over-quarter.
  • 7 funds opened new Aldeyra Therapeutics positions in Q1 2016 and 0 closed out, a net change of +7 holders.
  • The largest Aldeyra Therapeutics buyer in Q1 2016 was DAFNA Capital Management, an estimated $847K added.
  • The largest Aldeyra Therapeutics seller in Q1 2016 was Deerfield Management, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2016.